Rapport Therapeutics, Inc. (RAPP) › Cash & EquivalentsRapport Therapeutics, Inc. (RAPP) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2023: $70.17M2024: $56.80M2025: $52.65M$52.65M2023Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$52.65M-7.3%2024$56.80M-19.0%2023$70.17M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share